These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2198822)

  • 1. Immunomodulation by intravenous immunoglobulin.
    Imbach P; Barandun S; Cottier H; Gugler E; Hassig A; Morell A; Wagner H; Heiniger H
    Am J Pediatr Hematol Oncol; 1990; 12(2):134-40. PubMed ID: 2198822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune thrombocytopenic purpura and intravenous immunoglobulin.
    Imbach P
    Cancer; 1991 Sep; 68(6 Suppl):1422-5. PubMed ID: 1878840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).
    Imbach P; Morell A
    Int Rev Immunol; 1989; 5(2):181-8. PubMed ID: 8691051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin, immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Proceedings of a workshop. Edinburgh, Scotland, 4 and 5 December 1986.
    J Infect; 1987 Jul; 15 Suppl 1():1-65. PubMed ID: 3117895
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy for idiopathic thrombocytopenic purpura and other immune-related disorders: review and update of our experiences.
    Imbach P
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S120-5. PubMed ID: 3135528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura.
    Bussel JB
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S147-55. PubMed ID: 2477185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy in cytopenia.
    Bussell J
    Vox Sang; 1986; 51 Suppl 2():69-73. PubMed ID: 3765552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of intravenous immunoglobulins in pediatrics].
    Duse M; Plebani A; Crispino P; Ugazio AG
    Pediatr Med Chir; 1991; 13(2):117-25. PubMed ID: 1896376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin: new clinical applications.
    Steele RW; Burks AW; Williams LW
    Ann Allergy; 1988 Feb; 60(2):89-94. PubMed ID: 2829663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group.
    Warrier I; Bussel JB; Valdez L; Barbosa J; Beardsley DS
    J Pediatr Hematol Oncol; 1997; 19(3):197-201. PubMed ID: 9201140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy: new aspects and outlook.
    Imbach P; Barandun S; Baumgartner C; Gaedicke G; Hirt A; Wagner HP
    Blut; 1984 Jun; 48(6):415-8. PubMed ID: 6540133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous gamma globulin in children and adolescents with idiopathic thrombocytopenic purpura and other immune thrombocytopenias.
    Lusher JM; Warrier I
    Am J Med; 1987 Oct; 83(4A):10-6. PubMed ID: 3118703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study.
    Imholz B; Imbach P; Baumgartner C; Berchtold W; Gaedicke G; Gugler E; Hirt A; Hitzig W; Mueller-Eckhardt C; Wagner HP
    Blut; 1988 Feb; 56(2):63-8. PubMed ID: 3277679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationship in the treatment of idiopathic thrombocytopenic purpura with intravenous immunoglobulin.
    Emmerich B; Hiller E; Woitinas F; Maubach PA; Riess H; Nerl C; Geursen RG
    Klin Wochenschr; 1987 Apr; 65(8):369-72. PubMed ID: 3295380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.
    Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim evaluation of two cooperative studies assessing the effects of intravenous immunoglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP): I. Randomized study comparing i.v. IgG with oral corticosteroids in previously untreated acute ITP. II. Prospective study of i.v. IgG in acute and chronic ITP unresponsive to previous treatment.
    Imbach P; Gaedicke G; Joller P
    Blut; 1984 Jun; 48(6):357-61. PubMed ID: 6540129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological effects of intravenous gammaglobulin treatment in childhood idiopathic thrombocytopenic purpura.
    Winiarski J; Elinder G
    Scand J Haematol; 1986 Sep; 37(3):175-9. PubMed ID: 3491418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous immunoglobulin in various medical conditions. A Japanese experience.
    Abe T; Kawasugi K
    Cancer; 1991 Sep; 68(6 Suppl):1454-9. PubMed ID: 1878844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease.
    Bussel JB; Hilgartner MW
    Br J Haematol; 1984 Jan; 56(1):1-7. PubMed ID: 6367804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous high-dose IgG therapy induced alterations of spleen lymphocyte IgM secretion and T cell subsets in patients with idiopathic thrombocytopenic purpura.
    Bordet JC; Follea G; Carosella E; Dechavanne M
    Thromb Res; 1987 Jul; 47(2):165-74. PubMed ID: 3499005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.